-
Mashup Score: 6
Three members share their advice on how to plan your schedule, make connections, and enjoy your time at AM24.
Source: connection.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 12024 Cancer Survivorship Walkathon - 26 day(s) ago
Dawood Findakly’s Fundraising Page.
Source: www.pledgereg.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Virtual Mentoring Program - 28 day(s) ago
ASCO’s Virtual Mentoring Program pairs members with a mentor outside of their institution to address unmet career development needs of practicing oncologists, populations underrepresented in
Source: society.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Combined Hematology/Oncology and Hospice & Palliative Medicine - 2 month(s) ago
This program targets trainees wanting to further their palliative care skills to be able to deliver high-quality cancer care with palliative/supportive care integrated across the continuum of care.
Source: society.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 67Precision treatment in advanced hepatocellular carcinoma - 3 month(s) ago
The past decade has witnessed significant advances in the systemic treatment of advanced hepatocellular carcinoma (HCC). Nevertheless, the newly devel…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 67Precision treatment in advanced hepatocellular carcinoma - 3 month(s) ago
The past decade has witnessed significant advances in the systemic treatment of advanced hepatocellular carcinoma (HCC). Nevertheless, the newly devel…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Bispecific antibodies for the treatment of B-cell lymphoma: promises, unknowns, and opportunities - 3 month(s) ago
Falchi and colleagues review the development of and clinical experience with bispecific antibodies, a class of T-cell redirecting drugs with excellent activity
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 18
Original Article from The New England Journal of Medicine — Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
Source: www.nejm.orgCategories: Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 38myelocast - 8 month(s) ago
A new Flutter project.
Source: eatoure.github.ioCategories: Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 6FDA Approves Momelotinib for Myelofibrosis With Anemia - 8 month(s) ago
The FDA has approved momelotinib (Ojjaara) for the treatment of adult patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis, and anemia.
Source: www.onclive.comCategories: Hem/Oncs, Latest HeadlinesTweet
RT @IvyLorena_Md: https://t.co/EI4J2slG5b